Evommune (EVMN) Interest Coverage Ratio (2024 - 2026)

Evommune (EVMN) posted quarterly Interest Coverage Ratio of 0.26 for Q1 2026, up 99.65% year-over-year from 0.13 in Q1 2025, and down 100.04% quarter-over-quarter from 691.07 in Q4 2025.

Evommune (EVMN) Interest Coverage Ratio (2024 - 2026) Analysis & Trends

Evommune (EVMN) has reported Interest Coverage Ratio for 3 consecutive years, with 0.26 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Interest Coverage Ratio rose 99.65% year-over-year to 0.26; the TTM figure through Mar 2026 stood at 0.89 (changed N/A YoY), while the FY2025 annual figure was 1.49, up 98.3% from the prior year.
  • Interest Coverage Ratio fell to 0.26 in Q1 2026 per EVMN's latest filing, from 691.07 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 691.07 in Q4 2025 and bottomed at 3575.67 in Q4 2024.
  • Historically, Interest Coverage Ratio has averaged 655.59 across 3 years, with a median of 38.54 in 2025.
  • Annual changes were most pronounced in 2025 — Interest Coverage Ratio soared 119.33% — and 2026, when it surged 99.65%.
  • Evommune's Interest Coverage Ratio stood at 3575.67 in 2024, then jumped by 119.33% to 691.07 in 2025, then tumbled by 100.04% to 0.26 in 2026.
  • Business Quant data shows EVMN's Interest Coverage Ratio at 0.26 in Q1 2026, 691.07 in Q4 2025, and 1.93 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 2.84
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 24.64
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -0.19
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 8.18
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -0.01
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.61
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 2.82
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.08
10 Evommune 531.53 Mn 330.73 Mn - -0.99

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.99
Mar 31, 2026 -0.26
Dec 31, 2025 691.07
Sep 30, 2025 -1.93
Mar 31, 2025 -75.16
Dec 31, 2024 -3,575.67
Sep 30, 2024 -971.59